Compass Therapeutics, Inc.
Compass Therapeutics, Inc.（CMPX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cmpx · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$10.40
+413.6% upside
Low
$6.00
Median: $9 · Last Close: $2.02
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$10.40
413.6% upside
High Target
$15
640.7%
Low Target
$6
196.3%
Current Price
$2.02
as of today
Based on analyst price targets, the CMPX stock price prediction for the next 12 months ranges from $6 to $15. The consensus CMPX price forecast of $10.40 implies 413.6% upside from the current price of $2.02.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.04 | ↑ 0.93% |
1-day model range: $2.03–$2.06. Peak: $2.06 (+0.93%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CMPX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-28 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-28 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-04-27 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-05 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-12 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-12 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-05-09 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Compass Therapeutics, Inc. (CMPX) stock. Of the recent 51 rating actions, 2 were upgrades and 0 were downgrades. 15 analysts currently cover CMPX.
分析师推荐趋势
CMPX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$-2M
↓ 101.9% YoY
Revenue Next Year
$26M
↓ 1179.1% YoY
EPS This Year
$-0.44
EPS Next Year
$-0.46
↑ 5.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CMPX EPS of $-0.44 for the current fiscal year, based on estimates from 11 analysts. The CMPX revenue forecast is $-2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CMPX 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CMPX 的共识目标价为 $10.40（+413.6% 上行空间），分析师共识为 Buy。
CMPX 的短期预测（明日）为 $2.04（+0.93%）。
Compass Therapeutics, Inc. 在 NASDAQ 上市，代码 CMPX。CMPX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CMPX 预测 · 8 个问题根据 15 位华尔街分析师，CMPX 的 12 个月平均目标价为 $10.40，最高 $15.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $2.02，隐含约 +413.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.